| Document and Entity Information - shares | 3 Months Ended | |
| Mar. 31, 2021 | May 21, 2021 | |
| Cover [Abstract] | ||
| Entity Registrant Name | Integrity Applications, Inc. | |
| Entity Central Index Key | 0001506983 | |
| Document Type | 10-Q | |
| Document Period End Date | Mar. 31, 2021 | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --12-31 | |
| Entity's Reporting Status Current | Yes | |
| Entity Interactive Data Current | Yes | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Small Business Flag | true | |
| Entity Emerging Growth Company | false | |
| Entity Shell Company | false | |
| Entity Common Stock, Shares Outstanding | 200,781,596 | |
| Document Fiscal Period Focus | Q1 | |
| Document Fiscal Year Focus | 2021 |
| Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
| Current Assets | ||
| Cash and cash equivalents | $ 8,887 | $ 9,823 |
| Accounts receivable, net | 69 | 66 |
| Inventory | 279 | 284 |
| Other current assets | 45 | 56 |
| Total current assets | 9,280 | 10,229 |
| Operating lease right-of-use assets, net | 149 | 166 |
| Property and equipment, net | 133 | 149 |
| Non-current Restricted Cash | 66 | 62 |
| TOTAL ASSETS | 9,628 | 10,606 |
| Current Liabilities | ||
| Accounts payable | 694 | 869 |
| Operating lease liabilities, current | 110 | 84 |
| Other current liabilities | 444 | 392 |
| Total Current Liabilities | 1,248 | 1,345 |
| Non-current Liabilities | ||
| Long-Term Loans from Stockholders | 192 | 197 |
| Operating lease liabilities, non-current | 39 | 82 |
| Total Non-current liabilities | 231 | 279 |
| Total Liabilities | 1,479 | 1,624 |
| Stockholders' Equity | ||
| Common Stock of $ 0.001 par value ("Common Stock"): 500,000,000 shares authorized; 200,781,064 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively | 201 | 201 |
| Additional paid-in capital | 102,214 | 102,165 |
| Accumulated other comprehensive income | 37 | 15 |
| Accumulated deficit | (94,303) | (93,399) |
| Total Stockholders' equity | 8,149 | 8,982 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 9,628 | $ 10,606 |
| Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2021 | Dec. 31, 2020 |
| Statement of Financial Position [Abstract] | ||
| Common stock, par value | $ 0.001 | $ 0.001 |
| Common stock, shares authorized | 500,000,000 | 500,000,000 |
| Common stock, shares issued | 200,781,064 | 200,781,064 |
| Common stock, shares outstanding | 200,781,064 | 200,781,064 |
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
| Mar. 31, 2021 | Mar. 31, 2020 | |
| Income Statement [Abstract] | ||
| Research and development expenses | $ 309 | $ 413 |
| Selling and Marketing | 23 | 91 |
| General and administrative expenses | 564 | 252 |
| Total operating expenses | 896 | 756 |
| Operating loss | 896 | 756 |
| Financing income (expense), net | (8) | 22 |
| Loss for the period | 904 | 734 |
| Other comprehensive income: | ||
| Foreign currency translation adjustment | 22 | 19 |
| Comprehensive Loss for the period | $ 882 | $ 715 |
| Loss per share (Basic and Diluted) | $ 0 | $ 0 |
| Common shares used in computing Basic and Diluted Loss per share | 200,781,064 | 181,790,919 |
| Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands | Common Stock [Member] | Additional Paid-in Capital [Member] | Receipt on Account of Shares [Member] | Accumulated Other Comprehensive Income [Member] | Accumulated Deficit [Member] | Total |
| Balance at Dec. 31, 2019 | $ 162 | $ 89,005 | $ 124 | $ (90,703) | $ (1,412) | |
| Balance, shares at Dec. 31, 2019 | 161,858,436 | |||||
| Loss for the period | (734) | (734) | ||||
| Other comprehensive income | 19 | 19 | ||||
| Issuance of Common Stock net of cash issuance costs | $ 38 | 12,215 | 12,253 | |||
| Issuance of Common Stock net of cash issuance costs, shares | 37,500,000 | |||||
| Issuance of shares as settlement of financial liabilities | 63 | 63 | ||||
| Issuance of shares as settlement of financial liabilities, shares | ||||||
| Warrants issued as consideration for placement services | 756 | 756 | ||||
| Stock-based compensation | 2 | 2 | ||||
| Balance at Mar. 31, 2020 | $ 200 | 101,978 | $ 63 | 143 | (91,437) | 10,947 |
| Balance, shares at Mar. 31, 2020 | 199,358,436 | |||||
| Balance at Dec. 31, 2020 | $ 201 | 102,165 | 15 | (93,399) | 8,982 | |
| Balance, shares at Dec. 31, 2020 | 200,781,064 | |||||
| Loss for the period | (904) | (904) | ||||
| Other comprehensive income | 22 | 22 | ||||
| Stock-based compensation | 49 | 49 | ||||
| Balance at Mar. 31, 2021 | $ 201 | $ 102,214 | $ 37 | $ (94,303) | $ 8,149 | |
| Balance, shares at Mar. 31, 2021 | 200,781,064 |
| Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
| Mar. 31, 2021 | Mar. 31, 2020 | |
| Cash flows from operating activities: | ||
| Loss for the period | $ (904) | $ (734) |
| Adjustments to reconcile loss for the period to net cash used in operating activities: | ||
| Depreciation | 12 | 12 |
| Stock-based compensation | 49 | 2 |
| Linkage difference on principal of loans from stockholders | 2 | |
| Changes in assets and liabilities: | ||
| Increase in accounts receivable | (5) | (2) |
| Increase in inventory | (6) | (47) |
| Decrease (increase) in other current assets | 10 | (53) |
| Decrease in accounts payable | (155) | (118) |
| Increase (Decrease) in other current liabilities | 64 | (49) |
| Net cash used in operating activities | (933) | (989) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | (15) | |
| Net cash used in investing activities | (15) | |
| Cash flows from financing activities | ||
| Issuance of Common Stock net of cash issuance expenses | 13,009 | |
| Net cash provided by financing activities | 13,009 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1 | (3) |
| Change in cash, cash equivalents, and restricted cash | (932) | 12,002 |
| Cash, cash equivalents, and restricted cash at beginning of the period | 9,885 | 476 |
| Cash, cash equivalents, and restricted cash at end of the period | $ 8,953 | $ 12,478 |
| Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) $ in Thousands | 3 Months Ended |
| Mar. 31, 2020USD ($)shares | |
| Fair value of warrants | $ 756 |
| Board of Member [Member] | |
| Fees paid | $ 63 |
| Issuance of shares | shares | 158,237 |
| General | 3 Months Ended |
| Mar. 31, 2021 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| General | NOTE 1 – GENERAL A. Integrity Applications, Inc. (the “Company”) was incorporated on May 18, 2010 under the laws of the State of Delaware. On July 15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter: “Integrity Acquisition”), a wholly owned Israeli subsidiary of the Company, which was established on May 23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter: “Integrity Israel”), an Israeli corporation that was previously held by the stockholders of the Company. Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger. Following the merger, Integrity Israel became a wholly-owned subsidiary of the Company. As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests. Integrity Israel was incorporated in 2001 and commenced its operations in 2002. Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and prediabetes. B. Since its incorporation, the Company’s material operations have all been carried out by Integrity Israel. The development and commercialization of Integrity Israel’s product is expected to require substantial expenditures. The Group has not yet generated significant revenues from operations, and therefore they are dependent upon external sources for financing their operations. As of March 31, 2021, the Company has an accumulated deficit of $94,303 thousand. In addition, in each year since its inception, the Company reported losses from operations and negative cash flows from operating activities On February 14, 2020, the Company closed on a $15 million private placement of its common stock, for which it received net cash in excess of $13,009 thousand. As of March 31,2021, the company had cash and cash equivalents in the amount of approximately $8,887 thousand, which is expected to be sufficient to meet its capital needs for at least 12 months from the date of issuance of these interim financial statements, thus the Company is expected to be able to operate as a going concern for at least 12 months from the date hereof. |
| Summary of Significant Accounting Policies | 3 Months Ended |
| Mar. 31, 2021 | |
| Accounting Policies [Abstract] | |
| Summary of Significant Accounting Policies | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES A. Basis of presentation Accounting Principles The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the Securities and Exchange Commission (“SEC”) on April 13, 2021. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company’s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature The results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any other interim period or for any future period. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiary. Significant intercompany balances and transactions have been eliminated in consolidation. Net Loss Per Share The Company computes net loss per share in accordance with ASC 260, “Earnings per share”. Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, net of the weighted average number of treasury shares (if any). Diluted loss per common share is computed similar to basic loss per share, except that the denominator is increased to include the number of additional potential shares of common stock that would have been outstanding if the potential shares of common stock had been issued and if the additional shares of common stock were dilutive. Potential shares of common stock are excluded from the computation for a period in which a net loss is reported or if their effect is anti-dilutive. An amount of 84,260,774 and 82,442,314 outstanding stock options and stock warrants have been excluded from the calculation of the diluted net loss per share for the period of three months ended March 31, 2021 and 2020, respectively, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive. B. Use of estimates in the preparation of financial statements The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to the determination of net realizable value of inventory. C. Reclassified Amounts Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications did not have material effect on the reported results of operations, shareholder’s equity or cash flows . |
| Leases | 3 Months Ended |
| Mar. 31, 2021 | |
| Leases [Abstract] | |
| Leases | NOTE 3 – LEASES The company has entered into several non-cancelable operating lease agreements for the company’s offices and few vehicles. The company’s leases have original lease periods expiring between 2021 and 2023. Payments due under such lease contracts include primarily fix payments. The company does not assume renewals in the determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement. The company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. The components of lease costs, lease term and discount rate are as follows: US dollars Three Months Ended March 31, 2021 (unaudited) Operating lease cost: Office space 29 Vehicles 15 44 Remaining Lease Term Office space 0.42 years vehicles 2.29 years Weighted Average Discount Rate Office space 10 % Vehicles 10 % The following is a schedule, by years, of maturities of operating lease liabilities as of March 31, 2021: US dollars March 31, 2021 (unaudited) Period: The remainder of 2021 101 2022 40 2023 22 Total operating lease payments 163 Less: imputed interest 14 Present value of lease liabilities 149 |
| Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
| Mar. 31, 2021 | |
| Accounting Policies [Abstract] | |
| Basis of Presentation | A. Basis of presentation Accounting Principles The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the Securities and Exchange Commission (“SEC”) on April 13, 2021. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company’s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature The results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any other interim period or for any future period. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiary. Significant intercompany balances and transactions have been eliminated in consolidation. Net Loss Per Share The Company computes net loss per share in accordance with ASC 260, “Earnings per share”. Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, net of the weighted average number of treasury shares (if any). Diluted loss per common share is computed similar to basic loss per share, except that the denominator is increased to include the number of additional potential shares of common stock that would have been outstanding if the potential shares of common stock had been issued and if the additional shares of common stock were dilutive. Potential shares of common stock are excluded from the computation for a period in which a net loss is reported or if their effect is anti-dilutive. An amount of 84,260,774 and 82,442,314 outstanding stock options and stock warrants have been excluded from the calculation of the diluted net loss per share for the period of three months ended March 31, 2021 and 2020, respectively, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive. |
| Use of Estimates in the Preparation of Financial Statements | B. Use of estimates in the preparation of financial statements The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to the determination of net realizable value of inventory. |
| Reclassified Amounts | C. Reclassified Amounts Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications did not have material effect on the reported results of operations, shareholder’s equity or cash flows . |
| Leases (Tables) | 3 Months Ended |
| Mar. 31, 2021 | |
| Leases [Abstract] | |
| Schedule of Lease Costs, Lease Term and Discount | The components of lease costs, lease term and discount rate are as follows: US dollars Three Months Ended March 31, 2021 (unaudited) Operating lease cost: Office space 29 Vehicles 15 44 Remaining Lease Term Office space 0.42 years vehicles 2.29 years Weighted Average Discount Rate Office space 10 % Vehicles 10 % |
| Schedule of Operating Lease Maturity Payments | The following is a schedule, by years, of maturities of operating lease liabilities as of March 31, 2021: US dollars March 31, 2021 (unaudited) Period: The remainder of 2021 101 2022 40 2023 22 Total operating lease payments 163 Less: imputed interest 14 Present value of lease liabilities 149 |
| General (Details Narrative) - USD ($) $ in Thousands | Feb. 14, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 |
| Accumulated deficit | $ (94,303) | $ (93,399) | ||
| Net proceeds from issuance of common stock | $ 13,009 | |||
| Cash and cash equivalents | $ 8,887 | $ 9,823 | ||
| Private Placement [Member] | ||||
| Gross proceeds from issuance of common stock | $ 15,000 | |||
| Net proceeds from issuance of common stock | $ 13,009 |
| Summary of Significant Accounting Policies (Details Narrative) - shares | 3 Months Ended | |
| Mar. 31, 2021 | Mar. 31, 2020 | |
| Accounting Policies [Abstract] | ||
| Outstanding shares excluded from calculation of diluted net loss per share | 84,260,774 | 82,442,314 |
| Leases - Schedule of Lease Costs, Lease Term and Discount (Details) $ in Thousands | 3 Months Ended |
| Mar. 31, 2021USD ($) | |
| Operating lease cost | $ 44 |
| Office Space [Member] | |
| Operating lease cost | $ 29 |
| Remaining Lease Term | 5 months 1 day |
| Weighted Average Discount Rate | 10.00% |
| Vehicles [Member] | |
| Operating lease cost | $ 15 |
| Remaining Lease Term | 2 years 3 months 15 days |
| Weighted Average Discount Rate | 10.00% |
| Leases - Schedule of Operating Lease Maturity Payments (Details) $ in Thousands | Mar. 31, 2021USD ($) |
| Leases [Abstract] | |
| The remainder of 2021 | $ 101 |
| 2022 | 40 |
| 2023 | 22 |
| Total operating lease payments | 163 |
| Less: imputed interest | 14 |
| Present value of lease liabilities | $ 149 |
